IL10 and allergic asthma: Further in vivo and clinical research should be pursued to evaluate therapeutic properties of B. bifidum BGN4 [pBESIL10] synthesizing IL-10 as a treatment for various inflammation-related diseases, including inflammatory bowel disease, rheumatoid arthritis, allergic asthma, and cancer immunotherapy.